Geneos Wealth Management Inc. Fulgent Genetics, Inc. Transaction History

Geneos Wealth Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$28.52 - $40.7 $570 - $814	20 Added 5.05%	416 $15,000
Q1 2023 Apr 25, 2023	SELL	$29.39 - $36.27 $587 - $725	-20 Reduced 4.81%	396 $12,000
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $2,844 - $4,780	-75 Reduced 15.27%	416 $15,000
Q1 2022 May 16, 2022	BUY	$49.85 - $96.11 $19,740 - $38,059	396 Added 416.84%	491 $30,000
Q4 2021 Feb 09, 2022	SELL	$77.3 - $105.0 $5,797 - $7,875	-75 Reduced 44.12%	95 $9,000
Q3 2021 Nov 09, 2021	BUY	$74.87 - $110.87 $1,497 - $2,217	20 Added 13.33%	170 $14,000
Q2 2021 Jul 08, 2021	SELL	$66.8 - $100.45 $20,374 - $30,637	-305 Reduced 67.03%	150 $13,000
Q4 2020 May 19, 2021	BUY	$31.01 - $52.1 $14,109 - $23,705	455 New	455 $43,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.